DOSE MEDICAL CORP has a total of 60 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets medical technology, pharmaceuticals and electrical machinery and energy are TU HOSHENG, WARD KEVIN R and DE JUAN JR EUGENE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 19 | |
#2 | WIPO (World Intellectual Property Organization) | 10 | |
#3 | EPO (European Patent Office) | 9 | |
#4 | Australia | 8 | |
#5 | Japan | 6 | |
#6 | Canada | 4 | |
#7 | China | 3 | |
#8 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Electrical machinery and energy | |
#4 | Computer technology | |
#5 | Environmental technology | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Implantable devices | |
#2 | Medical preparations | |
#3 | Syringes | |
#4 | Object sterilising | |
#5 | Therapeutic chemical compounds | |
#6 | Diagnosis and surgery | |
#7 | Reduction of greenhouse gas emissions | |
#8 | Batteries | |
#9 | Healthcare informatics | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Haffner David S | 26 |
#2 | Burns Thomas W | 23 |
#3 | Heitzmann Harold A | 21 |
#4 | Applegate David | 18 |
#5 | Haffner David | 17 |
#6 | Heitzmann Harold | 15 |
#7 | Curry Kenneth M | 14 |
#8 | Curry Ken | 12 |
#9 | Curry Kenneth Martin | 8 |
#10 | Bergheim Olav B | 6 |
Publication | Filing date | Title |
---|---|---|
WO2021026214A1 | Bioerodible cross-linked hydrogel implants and related methods of use | |
WO2020243602A1 | Bioerodible cross-linked hydrogel implants and related methods of use | |
US2020375889A1 | Bioerodible polyester polymer implants and related methods of use | |
US2019125581A1 | Bioresorbable ocular drug delivery device | |
WO2017040855A1 | Drug delivery implants as intraocular drug depots and methods of using same | |
WO2015184173A1 | Implants with controlled drug delivery features and methods of using same | |
WO2015073571A1 | Ocular implants configured to store and release stable drug formulations | |
US2014303544A1 | Implants with controlled drug delivery features and methods of using same | |
WO2013040079A1 | Intraocular physiological sensor | |
EP2654715A2 | Drug eluting ocular implant | |
AU2010249683A1 | Drug eluting ocular implant |